Opexa Reports Second Quarter 2007 Financial Results
PharmaLive.com (press release) - Newtown,PA,USA
... offset in part by the increase in costs of the Phase IIb trial for Tovaxin. Opexa Therapeutics develops and commercializes cell therapies to treat ...
See all stories on this topic